Abstract

Defective bone formation is common in patients with diabetes, suggesting that insulin normally exerts anabolic actions in bone. However, because insulin can cross-activate the insulin-like growth factor type 1 receptor (IGF-1R), which also functions in bone, it has been difficult to establish the direct (IGF-1-independent) actions of insulin in osteoblasts. To overcome this problem, we examined insulin signaling and action in primary osteoblasts engineered for conditional disruption of the IGF-1 receptor (DeltaIGF-1R). Calvarial osteoblasts from mice carrying floxed IGF-1R alleles were infected with adenoviral vectors expressing the Cre recombinase (Ad-Cre) or green fluorescent protein (Ad-GFP) as control. Disruption of IGF-1R mRNA (>90%) eliminated IGF-1R without affecting insulin receptor (IR) mRNA and protein expression and eliminated IGF-1R/IR hybrids. In DeltaIGF-1R osteoblasts, insulin signaling was markedly increased as evidenced by increased phosphorylation of insulin receptor substrate 1/2 and enhanced ERK/Akt activation. Microarray analysis of RNA samples from insulin-treated, DeltaIGF-1R osteoblasts revealed striking changes in several genes known to be downstream of ERK including Glut-1 and c-fos. Treatment of osteoblasts with insulin induced Glut-1 mRNA, increased 2-[1,2-(3)H]-deoxy-d-glucose uptake, and enhanced proliferation. Moreover, insulin treatment rescued the defective differentiation and mineralization of DeltaIGF-1R osteoblasts, suggesting that IR signaling can compensate, at least in part, for loss of IGF-1R signaling. We conclude that insulin exerts direct anabolic actions in osteoblasts by activation of its cognate receptor and that the strength of insulin-generated signals is tempered through interactions with the IGF-1R.

Highlights

  • Insulin and insulin-like growth factor 1 (IGF-1)2 are related signaling molecules that evolved from a common ancestor pathway originally involved in sensing and integrating signals arising from nutrient and growth factor availability

  • These findings provide the first ing the osteoblasts) were pooled together, centrifuged, washed unequivocal evidence for direct actions of insulin on osteo- with ␣MEM containing 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, blasts and suggest that the strength of insulin generated signals and plated overnight at 37 °C in a humidified incubator supin this cell type is tempered through interactions with insulinlike growth factor type 1 receptor (IGF-1R). plied with 5% CO2

  • insulin receptor (IR)/IGF-1R hybrid receptor were clearly detected in cells expressing both IR and IGF-1R but were greatly diminished in ⌬IGF-1R osteoblasts (Fig. 1, F and G)

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Cell culture medium, ␣-minimal essential with adenovirus encoding Cre recombinase (Ad-Cre) (Vector medium (␣MEM), was obtained from Cellgro-Mediatech (Her- Biolabs, Philadelphia, PA) at a titer of 100 multiplicity of infecdon, VA), and fetal bovine serum (FBS) was from Invitrogen. tion (MOI). The cells were serum-starved in 0.05% FBS for 48 h and blasts were replated on 100-mm tissue culture plates for restimulated with 100 nM insulin for 24 h. For signaling experiments, ⌬IGF-1R and control cells were cul- and subsequently purified as per TrueLabeling-AMPTM prototured in 10% FBS ␣MEM to 90% confluence and serum- col recommended by manufacturer (SuperArray Bioscience starved in 0.1% bovine serum albumin for 24 h to reduce cellular Corp., Frederick, MD). Alkaline Phosphatase and von Kossa Staining—The ⌬IGF-1R and control osteoblasts were cultured in 6-well plates with 2.0 ϫ 105 cells/well in ␣MEM with 10% FBS for 4 days until they were confluent. [3H]2-Deoxyglucose (2-DOG) Uptake Assay—The ⌬IGF-1R and control osteoblasts were cultured in 12-well plates till confluent. The values are expressed as the means Ϯ S.E

RESULTS
DISCUSSION
GenBankTM accession number
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call